Inhibitors of SARS-CoV-2 main protease: Biological efficacy and toxicity aspects.

Viskupicova, Jana; Rezbarikova, Petronela; Kovacikova, Lucia; Kandarova, Helena; Majekova, Magdalena

Viskupicova, Jana; Rezbarikova, Petronela; Kovacikova, Lucia; Kandarova, Helena; Majekova, Magdalena.

Afiliación

Viskupicova J; Centre of Experimental Medicine, Slovak Academy of Sciences, Bratislava, Slovakia.
Rezbarikova P; Centre of Experimental Medicine, Slovak Academy of Sciences, Bratislava, Slovakia.
Kovacikova L; Centre of Experimental Medicine, Slovak Academy of Sciences, Bratislava, Slovakia; Department of Organic Chemistry, Faculty of Natural Sciences, Comenius University, Bratislava, Slovakia.
Kandarova H; Centre of Experimental Medicine, Slovak Academy of Sciences, Bratislava, Slovakia; Institute of Biochemistry and Microbiology, Faculty of Chemical and Food Technology, Slovak University of Technology, Bratislava, Slovakia.
Majekova M; Centre of Experimental Medicine, Slovak Academy of Sciences, Bratislava, Slovakia. Electronic address: magdalena.majekova@savba.sk.

Toxicol In Vitro ; 92: 105640, 2023 Oct.

Article en En | MEDLINE | ID: mdl-37419426

Asunto(s)

COVID-19; Humanos; SARS-CoV-2; Síndrome Post Agudo de COVID-19; Estudios Prospectivos; Antivirales/farmacología; Simulación del Acoplamiento Molecular

Palabras clave

ADMET; Anti-inflammatory; Antibacterial; COVID-19; M(pro) inhibitors; Specific; toxicity.

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Toxicol In Vitro Asunto de la revista: TOXICOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Eslovaquia Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google